AllPennyStocks.com

Teaching Investors How To Turn Pennies Into Dollars TM


Subscribe to our free newsletter:

 Quote:   Symbol Lookup  (TSX = T.xxx, TSX-V = V.xxx)


Advertising    Contact Us    Message Boards
 
   

MLTO: Providing Health Solutions To The Hispanic Community

by Glenn Wilkins - AllPennyStocks.com News Reporter

November 9, 2005 (AllPennyStocks.com Media, Inc.) - People in general, and businesses in particular, ignore a socio-economic trend very much on the rise, that more and more Americans have Spanish as their mother tongue than pretty much any other language, excepting English. It is a trend that George W. Bush used to his advantage in both 2000 and 2004, by courting votes among the Hispanic community to win the White House (as he had done the governor's chair in Texas before that). While it is sometimes a mistake to cater exclusively to any one ethnic group, a company that appears to be doing so, and see its fortunes looking up as a result, is MEDirect Latino Incorporated (MLTO:Pink Sheets). The Plantation, Florida-based firm prides itself as the first national provider of direct-to-consumer Medicare reimbursed medical products, focused exclusively on chronic diseases affecting the Hispanic community.

The company is currently fixating much of its attention on the distribution of products for the treatment of Type II Diabetes, which apparently has hit the Hispanic demographic 120-percent harder than non-Hispanic whites in America. MEDirect Latino is also targeting type II Diabetes because of its unique status within the Medicare reimbursement regime and its high degree of correlation to other diseases such as high blood pressure and heart disease.

The current Latino market for MEDirect's products is conservatively estimated near $750 Million (all figures in U.S. dollars unless specified otherwise). It represents a huge opportunity for investors, given that 2.3 Million Hispanics are over 65, and eligible for Medicare benefits. MEDirect Latino is the only company catering to this market as a direct-to-consumer Medicare provider on an authentically national level. Attractive agreements with diabetes medication suppliers such as Bayer, Roche, Johnson & Johnson's LifeScan and Vital Care Group help position the company to aim higher and wider.

 

In September, the company expanded beyond its home base of Florida, to open a satellite distribution and service facility in San Juan, Puerto Rico, an expansion that could add a quarter-Million potential customers to the company's penetration plans in Puerto Rico, an eligible market of more than $300 Million.

The company's executive team has over 100 years of continued business development experience with corporations ranging from NBC television, Mercy Hospital Group, Logan Pharmaceuticals and AmeriSource.

The Medicare reimbursable direct-to-consumer business was given a (pardon the expression) shot in the arm by the Federal Balanced Budget Act of 1998 in Congress, which declared diabetes an "epidemic disease", thus broadening the scope of Medicare reimbursement for products distributed directly to consumers. It facilitated such patients having access to such necessary products as blood glucose meters, test strips and lancing devices from their local pharmacies.

With a board of directors so experienced in media, it was only a matter of time before such products hit the nation's airwaves, pages and computer screens. In September, MEDirect Latino kicked off a national media launch with the placement of national ads on Telemundo network in the States, while continuing to advertise in Puerto Rico on Telemundo, Univision and local cable channels.

Within a matter of weeks, the company noted a 78-percent hike in average daily call volume, sparking projections of new patient shipments exceeding 2,650 clients by the end of October, or better than double the September operating results that it announced. MEDirect also felt confident enough to revise upwards its revenue projections from $10 Million to $15 Million, and net profit estimates from $2 Million to $5 Million by the end of its current fiscal year (May 2006).

MEDirect Latino reports gross billings of $145,984 during August, a 75-percent increase over July billings. The Company realized gross product profit margins of 74 percent during the period, compared to 68 percent in July. This follows a revenue hike topping 400 percent for the spring-to-summer quarter, over above the same quarter of 2004.

Mother Nature provided the only black cloud on the horizon (literally) in the form of Hurricane Wilma, which ransacked South Florida in late October. Even so, with its commitment to customer service, the company's national ad and customer call intake center were up and running within a matter of days, its service, processing and warehouse facilities in Plantation, Florida sustaining only minor damage.

MEDirect Latino, which trades on the Pink Sheets under the symbol MLTO, appears also to have weathered the dreaded "October effect" which traditionally leaves other equities washed up on shore. It has not come, however, without its share of volatility. The price knew 52-week summits and ditches in just a matter of weeks, dipping to $1.20 early in July, before soaring to a high of $4.85 in the third week of sepulchral October. Early November saw MEDirect's price plateau around $4.35.

Still, given the initial effects of the company's media campaign, and the potentially huge market for its products and services - and the speed with which it appears able to deliver that service - this is a company bent on staying on radar screens nationwide.

 

Copyright © 2007 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

 

 

 


 

AllPennyStocks.com © 1999 - 2008. AllPennyStocks.com is a web publishing venture produced by AllPennyStocks.com Media, Inc.